Ibuprofen Lysine: Medgend

Ibuprofen Lysine FDA Approved Drugs

IBUPROFEN LYSINE [Ibuprofen Lysine^{C₁₃H₁₈O₂C₆H₁₄N₂O₂}]

eq 20mg base/2ml (eq 10mg base/ml) (intravenous injectable)

Exela Pharma Science^{Mar 30, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

NEOPROFEN [Ibuprofen Lysine^{C₁₃H₁₈O₂C₆H₁₄N₂O₂}]

eq 20mg base/2ml (eq 10mg base/ml) (intravenous injectable)

Recordati Rare^{Apr 13, 2006}

Closure of a clnically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g, who are no more than 32 weeks gestational age when usual medical management is ineffective.
Treatment of patent ductus arteriosus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.